Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Arthralgia, Eye pain, Facial pain, Headache, Migraine
Clinical narrative: Left arm injection site pain persisting, swelling and redness; Left arm injection site pain persisting, swelling and redness; Left arm injection site pain persisting, swelling and redness; Pain down left arm; progressive radiation of pain to top of left shoulder; progressive radiation of pain to top of left shoulder,left side of neck; progressive radiation of pain to top of left shoulder, left side of neck, left side of back of head to left side of face and left eye; progressive radiation of pain to top of left shoulder, left side of neck, left side of back of head to left side of face and left eye; progressive radiation of pain to top of left shoulder, left side of neck, left side of back of head to left side of face and left eye; Brief visual migraine; This is a spontaneous report from a contactable nurse. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 09:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included Hashimoto's disease. Concomitant medications included levothyroxine sodium (SYNTHROID), nicotinamide, pyridoxine hydrochloride, riboflavin, thiamine hydrochloride (B COMPLEX) and naproxen sodium (ALEVE), all taken for unspecified indications from unknown dates. The patient previously took gadolinium and experienced drug allergy (nasal congestion). The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER6207) via an unspecified route of administration in the left arm on 19Mar2021 at 09:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 09:50, approximately 20 minutes after injection, the patient experienced pain down left arm, progressive radiation of pain to top of left shoulder, left side of neck, left side of back of head to left side of face and left eye and brief visual migraine (flashing zigzag lines for less than one minute). Pain decreased in intensity after 2 hours and the eye symptoms were minimal by 17:00 on the same day. On 10Apr2021, second day after vaccination, the patient experienced left arm injection site pain, swelling and redness and were still present on 11Apr2021, third day after vaccination and was 4x7 centimeters. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events pain in arm, shoulder, neck, back of head, face and eye on left side, visual migraine and injection site pain, swelling and redness were recovering at the time of this report.  No follow-up attempts are needed. No further information is expected.